≡

Polyclonal Antibody to Phospholipase A2 Group VII (LpPLA2)

PLA2G7; PAF-AH; PAFAH; Lp-PLA2; LDL-PLA2; Platelet Activating Factor Acetylhydrolase,Plasma; Phospholipase A2,Group VII; LDL-associated phospholipase A2; Phospholipase A2, Lipoprotein Associated

SPECIFITY

The antibody is a rabbit polyclonal antibody raised against LpPLA2. It has been selected for its ability to recognize LpPLA2 in immunohistochemical staining and western blotting.

USAGE

Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Science & Sports The effects of different intensity walking programs on serum blood lipids, high-sensitive C-reactive protein, and lipoprotein-associated phospholipase A2 in premenopausal women ScienceDirect: S0765159710000262
Metabolic Syndrome and Related Disorders Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease Wiley: source
34 Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study PubMed: 22240497
PLoS ONE Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo PubMed: PMC3759413
China Pharmacy Influence of Tongfengtai Granules on Inflammatory Factor in Acute Gouty Arthritis Model Rats Source
Atherosclerosis Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients. Pubmed: 23958269
Journal of Diabetes Research Lipoprotein-Associated Phospholipase A2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus Hindawi: 278063
Health The Role of Asymmetric Dimethylarginine and Lipoprotein Associated Phospholipase A2 in Children and Adolescents with Dyslipidemia Scirp:Source
Biology Bulletin In vitro lipid-lowering and fibrinolytic effects of regulatory leucine-containing glyprolines in human blood Springer:Source
Gynecol Endocrinol. Lipoprotein-associated phospholipase A2 and AGEs are associated with cardiovascular risk factors in women with history of gestational diabetes mellitus. Pubmed:24397392
Journal of Diabetes Research Lipoprotein-Associated Phospholipase A 2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus Pubmed:24818163
Metabolism. Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes Pubmed:25034387
J Am Heart Assoc Effect of Extended‐Release Niacin on High‐Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin‐Treated Patients PubMed: 26374297
Czecho-Slovak Dermatology / Cesko-Slovenska Dermatologie V Ebscohost
Endocrinol Metab (Seoul). Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA2 in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome pmc:PMC4803547
Clin Pharmacol Ther.  Effect of dipyridamole on myocardial reperfusion injury: A double‐blind randomized controlled trial in patients undergoing elective coronary artery bypass surgery Pubmed:25773594
Lipids in Health and Disease Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A 2 and secretory phospholipase A 2 in patients with newly … articles:10.1186
Acta Endocrinologica SERUM LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN MALES WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNEA. jrnl:1841098
Biomarker for diagnosis of moyamoya disease :
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions Pubmed: 32859455
chinese neurosurgical journal Can admission lipoprotein-associated phospholipase A2 predict the symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage?
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA867Hu02 Recombinant Phospholipase A2 Group VII (LpPLA2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA867Hu03 Recombinant Phospholipase A2 Group VII (LpPLA2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA867Hu04 Recombinant Phospholipase A2 Group VII (LpPLA2) Positive Control; Immunogen; SDS-PAGE; WB.
APA867Hu01 Active Phospholipase A2 Group VII (LpPLA2) Cell culture; Activity Assays.
RPA867Hu01 Recombinant Phospholipase A2 Group VII (LpPLA2) Positive Control; Immunogen; SDS-PAGE; WB.
PAA867Hu01 Polyclonal Antibody to Phospholipase A2 Group VII (LpPLA2) WB; IHC; ICC; IP.
LAA867Hu81 FITC-Linked Polyclonal Antibody to Phospholipase A2 Group VII (LpPLA2) WB; IHC; ICC; IF.
LAA867Hu71 Biotin-Linked Polyclonal Antibody to Phospholipase A2 Group VII (LpPLA2) WB; IHC; ICC.
MAA867Hu21 Monoclonal Antibody to Phospholipase A2 Group VII (LpPLA2) WB; IHC; ICC; IP.
MAA867Hu22 Monoclonal Antibody to Phospholipase A2 Group VII (LpPLA2) WB; IHC; ICC; IP.
SEA867Hu ELISA Kit for Phospholipase A2 Group VII (LpPLA2) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA867Hu CLIA Kit for Phospholipase A2 Group VII (LpPLA2) Chemiluminescent immunoassay for Antigen Detection.
LMA867Hu Multiplex Assay Kit for Phospholipase A2 Group VII (LpPLA2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.